Results demonstrated that PTPN22 knockdown significantly increased tyrosine phosphorylation levels of CBL in RCC cells (Figure 3E), while subsequent PTPN22 overexpression significantly reversed phosphorylation levels (Figure 3F). The gene discussed is CBL; the disease is renal cell carcinoma.